Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100041787Phase 4Recruiting
Phase 4, randomised trial of esketamine, sponsored by Tianjin Fourth Central Hospital. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100041787.